JP Morgan Chase’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

JP Morgan Chase’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-82,900	Closed	-$1.21M	–	7557
2023 Q1	$1.21M	Buy	+82,900	New	+$1.17M	﹤0.01%	3903

JP Morgan Chase's AMYT Position: Q2 2023 in Review

JP Morgan Chase sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 3,073 shares — an estimated $45K sold.

JP Morgan Chase first reported a position in AMYT in Q1 2021 and held it in 9 quarters. The position peaked at $45K in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

JP Morgan Chase reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
JP Morgan Chase sold 3,073 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $45K.
JP Morgan Chase first reported a position in Amryt Pharma plc American Depositary Shares in Q1 2021 and held it in 9 quarters.
JP Morgan Chase's Amryt Pharma plc American Depositary Shares position peaked at $45K in Q1 2023.
0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.